I recognized most names in the GILD acquisition target survey, except for UTHR. I quickly browsed their website and came across what I think has to be the single strangest, most esoteric website I've ever seen in pharma/biotech. Take the pipeline and leadership team pages for example:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.